Gnanaprakasam, J N Rashida <br/><br/>
The antineoplastic agent anacardic 6-pentadecyl salicylic acid produces immunomodulation in vivo via the activation of MAPKs.  [electronic resource] 

 -  Toxicology and applied pharmacology  08 2019 
 - 82-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-0333 
<br/><br/><label>Standard No.: </label>10.1016/j.taap.2019.05.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anacardic Acids--pharmacology<br/>Animals<br/>Cell Count<br/>Enzyme Activation--drug effects<br/>Female<br/>Granulocyte-Macrophage Colony-Stimulating Factor<br/>Immune System--drug effects<br/>Killer Cells, Natural--drug effects<br/>Leukocyte Count<br/>Macrophage Activation--drug effects<br/>Macrophages--drug effects<br/>Mice<br/>Mice, Inbred BALB C<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Phagocytosis--drug effects<br/>Phosphorylation--drug effects